- Home
- APVO vs IVP Comparison
APVO vs IVP Comparison
Compare APVO & IVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APVO
- IVP
- Stock Information
- Founded
- APVO 2016
- IVP 2020
- Country
- APVO United States
- IVP United States
- Employees
- APVO N/A
- IVP N/A
- Industry
- APVO Biotechnology: Pharmaceutical Preparations
- IVP Diversified Commercial Services
- Sector
- APVO Health Care
- IVP Miscellaneous
- Exchange
- APVO Nasdaq
- IVP Nasdaq
- Market Cap
- APVO 4.1M
- IVP 3.4M
- IPO Year
- APVO N/A
- IVP 2023
- Fundamental
- Price
- APVO $1.61
- IVP $0.92
- Analyst Decision
- APVO Strong Buy
- IVP
- Analyst Count
- APVO 1
- IVP 0
- Target Price
- APVO $5,920.00
- IVP N/A
- AVG Volume (30 Days)
- APVO 162.7K
- IVP 2.9M
- Earning Date
- APVO 11-06-2025
- IVP 08-13-2025
- Dividend Yield
- APVO N/A
- IVP N/A
- EPS Growth
- APVO N/A
- IVP N/A
- EPS
- APVO N/A
- IVP N/A
- Revenue
- APVO N/A
- IVP $15,292,904.00
- Revenue This Year
- APVO N/A
- IVP N/A
- Revenue Next Year
- APVO N/A
- IVP N/A
- P/E Ratio
- APVO N/A
- IVP N/A
- Revenue Growth
- APVO N/A
- IVP N/A
- 52 Week Low
- APVO $1.54
- IVP $0.63
- 52 Week High
- APVO $381.10
- IVP $36.75
- Technical
- Relative Strength Index (RSI)
- APVO 28.32
- IVP 49.32
- Support Level
- APVO $1.56
- IVP $0.88
- Resistance Level
- APVO $1.73
- IVP $1.01
- Average True Range (ATR)
- APVO 0.14
- IVP 0.09
- MACD
- APVO 0.02
- IVP 0.01
- Stochastic Oscillator
- APVO 11.29
- IVP 38.30
About APVO Aptevo Therapeutics Inc.
Aptevo Therapeutics Inc is a clinical-stage research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidates are; ALG.APV-527, which targets co-stimulatory receptors and tumor antigens, and CD3xCD123, which is being developed as a potential treatment of frontline acute myelogenous leukemia. The company's preclinical candidates, APVO711, APVO0442, and APVO603, are being developed using the ADAPTIR modular protein technology platform. The company's versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.
About IVP Inspire Veterinary Partners Inc.
Inspire Veterinary Partners Inc owns and operates veterinary hospitals throughout the United States. The company specializes in small animal general practice hospitals that serve all manner of companion pets, emphasizing canine and feline breeds.